Researchers are working to develop a pill to treat this serious inherited bleeding disorder. Oral delivery of the treatment–clotting factor IX–would allow individuals with type B hemophilia to swallow a pill rather than be subjected to several weekly injections of factor IX to control potentially fatal bleeding episodes.